Current management of a donor insemination program.
Substantial evidence now exists to show that considerable maternal-fetal morbidity may result from microbiologic transmitted diseases that can be transmitted through artificial insemination by donor. In the present decade it has become increasingly clear that the use of fresh semen is potentially hazardous and its use has been discouraged by both the CDC and AFS. To minimize this risk, donor insemination programs should establish their own guidelines to thoroughly evaluate potential semen donors via history, physical examination, and laboratory evaluation before the use of donor semen after cryopreservation and quarantine. The management of a donor insemination program in the future requires uniform procedures for rigorous genetic and microbiologic screening before the selection and use of semen donors for artificial insemination.
Hummel
W P
WP
Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill.
Talbert
L M
LM
D005260:Female; D006801:Humans; D007315:Insemination, Artificial; D007316:Insemination, Artificial, Heterologous; D008297:Male; D008487:Medical History Taking; D010353:Patient Education as Topic; D012749:Sexually Transmitted Diseases / Q000175:diagnosis / Q000635:transmission